imaGenes Overview

  • Founded
  • 2007
  • Status
  • Acquired/​Merged
  • Employees
  • 30
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

imaGenes General Information


Manufacturer of bioinfomatic products. The company's bioinfomatic products include genomic clone products, antibodies and RNA interference products, in addition to manufacturing of bioinfomatic products , the company also engages in research and development of DNA sequencing, genotyping and gene expression, enabling life science research and healthcare companies with new products and services to find the solution to complex diseases.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Robert-Rössle-Street.10
  • 13125 Berlin
  • Germany
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

imaGenes Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore imaGenes‘s full profile, request access.

Request a free trial

imaGenes Executive Team (3)

Name Title Board Seat Contact Info
Martin Stock Co-Founder and Director
Johannes Maurer Ph.D Chief Executive Officer
Steffen Hennig Ph.D Co-Founder, Director and Head of Bioinformatics
To view imaGenes’s complete executive team members history, request access »

imaGenes Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial